Garry Michael Kann
Corporate Officer/Principal en ENDONOVO THERAPEUTICS, INC. .
Perfil
Garry Michael Kann is currently the Head of Corporate Development at Endonovo Therapeutics, Inc. and a Partner at The Firebird Partnership Ltd.
He obtained an undergraduate degree from Kean University.
Cargos activos de Garry Michael Kann
| Empresas | Cargo | Inicio |
|---|---|---|
| ENDONOVO THERAPEUTICS, INC. | Corporate Officer/Principal | 01/03/2022 |
The Firebird Partnership Ltd.
 The Firebird Partnership Ltd. Financial ConglomeratesFinance The Firebird Partnership Ltd. provides investment services. The private company is based in Winchester, UK. The British company was founded in 2020 by Stewart Alexander Lambert, Ian Stuart Finlay. | Corporate Officer/Principal | - |
Formación de Garry Michael Kann.
| Kean University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ENDONOVO THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
The Firebird Partnership Ltd.
The Firebird Partnership Ltd. Financial ConglomeratesFinance The Firebird Partnership Ltd. provides investment services. The private company is based in Winchester, UK. The British company was founded in 2020 by Stewart Alexander Lambert, Ian Stuart Finlay. | Finance |
- Bolsa de valores
- Insiders
- Garry Michael Kann